December 27, 2018
Article
Clinical Trial Focus
Because the drug candidate has shown a competitive efficacy and safety profile compared with existing drugs in recent partial focal epilepsy studies, a phase 3 study was initiated.
December 26, 2018
Article
NeuroPathways
Gene therapy has generated excitement as a treatment or even a potential cure for inherited diseases. Among them: Duchenne muscular dystrophy.
December 21, 2018
Article
Clinical Viewpoint
The principal research scientist at Neuroscience Research Australia and an associate professor of medicine at the University of New South Wales provided more insight into the latest knowledge regarding sleep apnea phenotyping and its role in the development of targeted pharmacotherapies.
December 20, 2018
Article
Features
With more than a dozen disease-modifying therapies, some have set their sights on developing an agent designed to promote remyelination.
December 19, 2018
Article
Features
Although telestroke programs show more success in bringing stroke care to patients, lingering challenges have prevented widespread implementation.
December 18, 2018
Article
Cover Story
Growing enthusiasm in the Parkinson disease research community largely centers on advances in understanding the genetic underpinnings of the disease.
Evusheld Increased Attenuated SARS-CoV-2 Antibodies From MS B-Cell Depleting Medications
NeurologyLive® Friday 5 — June 24, 2022
Exploiting Anti-CD3 Antibodies, Relevant Biomarkers in Progressive MS: Tanuja Chitnis, MD
FDA Places Clinical Hold on Duchenne Muscular Dystrophy Drug SRP-5051 Amid Safety Concerns